Neurelis, Inc.

We are excited to participate in the American Academy of Neurology annual meeting, where we'll be presenting two posters. Learn more about our presentations at #AANAM: https://bit.ly/49wzZzg

Nurses are vital to healthcare. This National Public Health Week, we extend our gratitude to all public health #nurses for their dedication to enhancing care for individuals with #epilepsy. Learn more! https://bit.ly/49geFhj #NPHW

Congratulations to Chuck DeWildt, Chief Commercial Officer at Neurelis, who will serve on the 2024 Advisory Board of Healthcare Businesswomen’s Association, a global nonprofit organization.   The Advisory Board provides strategic direction on how the HBA can further the advancement of women’s careers in healthcare worldwide through its initiatives.

#ICYMI: We recently hosted an investor conference, sharing exciting updates on our #CNS pipeline. Catch the replay of the event here: https://bit.ly/3JlbDOl We're committed to advancing solutions in both rare and broader CNS disease areas.

Our recent manuscript on treating acute agitation in schizophrenia or bipolar disorder patients with intranasal formulations was published in The Journal of Clinical Psychiatry. For further details, visit: https://bit.ly/3TxBTuy

#ICYMI Craig Chambliss, CEO, sat down with Biotech2050 to discuss contributing to the #epilepsy and #CNS space. To listen to the full podcast episode, visit: https://bit.ly/3IuNJ24

Join Neurelis for a virtual investor call on Thurs. March 7 at 10:30 am ET to highlight updates on two of its product candidates, featuring Leslie Lucien Citrome, MD, MPH, discussing treatment of acute agitation episodes, and Issam Awad, MD, MSc, FACS, MA and Connie Lee, PsyD, discussing treatment of Cerebral Cavernous Malformations. Register here: https://bit.ly/3IoHpt2

Join us in raising awareness for #epilepsy on #RareDiseaseDay. Foundations for rare diseases such as Dravet Syndrome Foundation, Angelman Syndrome Foundation, and Lennox-Gastaut Syndrome (LGS) Foundation are working to significantly impact the lives of patients and families. Learn more about #RareEpilepsy here: https://bit.ly/3wCZfWN

Our manuscript was recently published in CNS Drugs, the peer-reviewed medical journal that covers drug treatment of psychiatric and #neurologicaldisorders. To read the full e-publication, visit: https://bit.ly/3uAyIsi

Did you know that over 20,000 African Americans are diagnosed with seizures or epilepsy each year? Show support this #BlackHistoryMonth by discovering how epilepsy impacts African American communities and how to best support them here: https://bit.ly/3IeEZhl